StockTipsArenaBeta

BUY Jubilant Ingrevia Limited — Shrikant Chouhan, Kotak Securities

BUYJubilant Ingrevia Limited
Jubilant Ingrevia share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: 1 year25 Sept 2026via Zee Business (Live)

Entry₹650.7Inferred
Target₹775
Total upside +19.10% (call closed)
Stop loss₹620-4.72% risk
Exit₹6208 Oct 2026, 3:13 pm
Stop-loss hit-4.72%
Follow Shrikant Chouhan for new callsGet alertsWatch JUBLINGREA for new buy/sell callsGet alertsSee 9 active Long-term calls on JUBLINGREASee 273 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Oct 2026
10 supporting6 neutral1 opposing
Supports the BUY call (10)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·24 Sept · 2w ago

Jubilant Ingrevia Shares Gain 3% As Kotak Securities Sees Sharp Earnings Growth Ahead; Retains 'Buy'

NewsNdtv-Profit·23 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (6)

The company incorporated a new wholly owned subsidiary.

BSE · Company Update·1 Oct · 6d ago

(opens in new tab)

The company board approved the incorporation of a wholly owned subsidiary.

NSE · Outcome of Board Meeting·1 Oct · 6d ago

(opens in new tab)

Jubilant Ingrevia Limited has issued Commercial Papers (CPs) of Rs. 100 Crores with a tenure of 90 days and a coupon rate of 6.30% per annum. The CPs are unsecured and listed on the National Stock Exc

NSE · Issue of Securities·24 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Jubilant Ingrevia

All analyst calls on Jubilant Ingrevia

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome